MAM
RGNX icon

Martingale Asset Management’s Regenxbio RGNX Stock Holding History

Martingale Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-39,950
Closed -$658K – 839
2023
Q3 		$658K Sell
39,950
-280
-0.7% -$5.07K 0.01% 552
2023
Q2 		$804K Sell
40,230
-400
-1% -$7.71K 0.02% 501
2023
Q1 		$768K Buy
40,630
+31,663
+353% +$701K 0.01% 514
2022
Q4 		$203K Buy
+8,967
New +$203K ﹤0.01% 791

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Martingale Asset Management's RGNX Position: Q4 2023 in Review

Martingale Asset Management sold out of Regenxbio (RGNX) in Q4 2023, closing a stake of 39,950 shares — an estimated $658K sold.

Martingale Asset Management first reported a position in RGNX in Q4 2022 and held it in 4 quarters. The position peaked at $804K in Q2 2023. 171 funds tracked by Wall St. Rank hold RGNX as of Q4 2023.

  • Martingale Asset Management reported no remaining Regenxbio position as of Q4 2023 after selling out during the quarter.
  • Martingale Asset Management sold 39,950 Regenxbio shares in Q4 2023, an estimated $658K.
  • Martingale Asset Management first reported a position in Regenxbio in Q4 2022 and held it in 4 quarters.
  • Martingale Asset Management's Regenxbio position peaked at $804K in Q2 2023.
  • 171 funds tracked by Wall St. Rank held Regenxbio as of Q4 2023.

Based on Martingale Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.